Datasheet
Safety Data Sheet (1907/2006/EC)
Material: 60008010 ELASTOSIL® N10 TRANSPARENT
Version: 3.0 (GB) Date of print: 22.08.2014 Date of last alteration: 13.02.2014
Page: 2/10
P-Code Precautionary Statements
P102 Keep out of reach of children.
P201 Obtain special instructions before use.
P280 Wear protective gloves/protective clothing/eye protection.
P281 Use personal protective equipment as required.
P405 Store locked up.
P501 Dispose of contents/container to waste disposal.
Hazard ingredients (labelling):
2-Butanone oxime
Silicic acid (H4SiO4), tetraethyl ester, RP with bis(acetyloxy)dibutylstannane
Special identification instructions:
Contains methyl-O,O',O''-butan-2-on-trioximo-silane, 2-butanone oxime, O ,O',O'',O'''-butan-2-ontetraoximosilane, 3-(2-
aminoethylamino)propyl trimethoxysilane. May produce an allergic reaction. Restricted to professional users.
Labelling (67/548/EEC, 1999/45/EC):
Xn
Harmful
R-Phrase Description
R40 Limited evidence of a carcinogenic effect.
S-Phrase Description
S36/37 Wear suitable protective clothing and gloves.
S51 Use only in well-ventilated areas.
Hazard ingredients (labelling EC):
2-Butanone oxime
Special identification instructions:
Contains: O,O',O'',O'''-Butan-2-ontetraoximosilane , 3-(2-aminoethylamino)propyl trimethoxysilane , 2-butanone oxime , Methyl-
O,O',O''-butan-2-on-trioximo-silane . May produce an allergic reaction.
2.3
Other hazards
In use the product releases 2-butanone oxime (methyl ethyl ketoxime; MEKO) which vaporises. 2-Butanone oxime (MEKO, CAS
96-29-7) is a dermal sensitizer and strongly irritating to the eyes. 2-Butanone oxime is rapidly absorbed from the gastrointestinal
tract, upon contact with skin and after inhalation. After oral exposure of rats to MEKO in an acute neurotoxicity study, transient
motor incoordination effects were observed. Prolonged exposure of animals led to damages of the olfactory epithelium and to an
increase in the incidence of corneal dystrophy and opacities. Systemic effects in repeated dose studies (oral, inhalative) were
hemolytic anemia and compensatory and extramedullary hematopoiesis as well as hemosiderosis in spleen and liver and
increased levels of methemoglobin. In several of these studies, the effects were reversible. Gross histopathologic alterations were
seen in spleen, lung and kidney. After chronic inhalative exposure to high vapor concentrations an increased incidence of
hepatocellular carcinomas and adenomas was observed predominantly in male rats and mice. The significance of these results to
human users has not been assessed.
SECTION 3: Composition/information on ingredients 3.
3.1
Substances
not applicable
3.2
Mixtures
3.2.1 Chemical characterization (preparation)
Polydimethylsiloxane and fillers and auxiliaries and oximosilane cross-linker